Fuller & Thaler Asset Management Inc. Has $146.95 Million Position in Option Care Health, Inc. $OPCH

Key Points

• Fuller & Thaler Asset Management Inc. increased its holdings in Option Care Health, Inc. by 30.8%, purchasing an additional 989,048 shares for a total of 4,204,481 shares, valued at approximately $146.9 million.
• Analysts have raised their price targets for Option Care Health to between $36.00 and $40.00, with an overall consensus rating of "Moderate Buy" and an average target price of $35.75.
• In its latest earnings report, Option Care Health reported $0.41 earnings per share, surpassing expectations, with quarterly revenue reaching $1.42 billion, a 15.4% increase year-over-year.

Fuller & Thaler Asset Management Inc. boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 30.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,204,481 shares of the company's stock after acquiring an additional 989,048 shares during the quarter. Fuller & Thaler Asset Management Inc. owned 2.57% of Option Care Health worth $146,947,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in OPCH. Wells Fargo & Company MN increased its stake in Option Care Health by 9.5% in the fourth quarter. Wells Fargo & Company MN now owns 180,391 shares of the company's stock valued at $4,185,000 after acquiring an additional 15,609 shares during the period. Raymond James Financial Inc. bought a new stake in Option Care Health in the fourth quarter valued at about $2,027,000. Sterling Capital Management LLC increased its stake in Option Care Health by 638.5% in the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock valued at $69,000 after acquiring an additional 2,554 shares during the period. Barclays PLC increased its stake in Option Care Health by 37.5% in the fourth quarter. Barclays PLC now owns 426,532 shares of the company's stock valued at $9,895,000 after acquiring an additional 116,338 shares during the period. Finally, Walleye Trading LLC increased its stake in Option Care Health by 159.7% in the fourth quarter. Walleye Trading LLC now owns 25,969 shares of the company's stock valued at $602,000 after acquiring an additional 15,969 shares during the period. Institutional investors own 98.05% of the company's stock.

Insider Activity at Option Care Health

In other Option Care Health news, Director Timothy P. Sullivan acquired 20,000 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The shares were acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the acquisition, the director directly owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This represents a 68.43% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the business's stock in a transaction that occurred on Wednesday, August 20th. The stock was acquired at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the acquisition, the director directly owned 375,390 shares of the company's stock, valued at $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.64% of the company's stock.

Wall Street Analysts Forecast Growth

OPCH has been the topic of a number of analyst reports. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Finally, Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Price Performance

Shares of OPCH stock traded up $0.90 during trading hours on Friday, reaching $28.74. 2,353,813 shares of the company were exchanged, compared to its average volume of 1,861,444. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The stock's fifty day moving average is $29.98 and its two-hundred day moving average is $31.77. The company has a market cap of $4.66 billion, a price-to-earnings ratio of 22.99, a P/E/G ratio of 1.72 and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period in the prior year, the business earned $0.30 earnings per share. Option Care Health's quarterly revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.